Pioneering diagnostics

bioMérieux Corporate Website | Pioneering diagnostics

bioMérieux acquires a majority stake in Hybiome    

Specialized in automated immunoassay tests, Hybiome develops, manufactures and markets a complete range of diagnostic solutions cleared by the China Food and Drug Administration. Thanks to this acquisition, we strengthen our presence both in China and in the immunoassay market.

Read more

Discover our clinical solutions

ENDOZYME® II GO launch

A new innovative test for the detection of endotoxins in pharmaceutical microbiology control resulting from the combined expertise of bioMérieux in microbiology and Hyglos GmbH in endotoxin detection.

Read the press release »

All our industry solutions

Annual report 2017

Download the report